Author response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease

Neurology. 2020 May 19;94(20):899. doi: 10.1212/WNL.0000000000009448.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adrenergic beta-2 Receptor Agonists
  • Humans
  • Parkinson Disease*

Substances

  • Adrenergic beta-2 Receptor Agonists